Correlation Between ResMed and Haemonetics

Can any of the company-specific risk be diversified away by investing in both ResMed and Haemonetics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ResMed and Haemonetics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between ResMed Inc and Haemonetics, you can compare the effects of market volatilities on ResMed and Haemonetics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ResMed with a short position of Haemonetics. Check out your portfolio center. Please also check ongoing floating volatility patterns of ResMed and Haemonetics.

Diversification Opportunities for ResMed and Haemonetics

-0.02

Correlation Coefficient

ResMed  Haemonetics

Good diversification

The 3 months correlation between ResMed and Haemonetics is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding ResMed Inc and Haemonetics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Haemonetics and ResMed is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ResMed Inc are associated (or correlated) with Haemonetics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Haemonetics has no effect on the direction of ResMed i.e., ResMed and Haemonetics go up and down completely randomly.

Pair Corralation between ResMed and Haemonetics

Considering the 90-day investment horizon ResMed is expected to generate 5.78 times less return on investment than Haemonetics. But when comparing it to its historical volatility, ResMed Inc is 1.3 times less risky than Haemonetics. It trades about 0.03 of its potential returns per unit of risk. Haemonetics is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  7,558  in Haemonetics on August 30, 2024 and sell it today you would earn a total of  1,231  from holding Haemonetics or generate 16.29% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

ResMed Inc  vs.  Haemonetics

ResMed Inc

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in ResMed Inc are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound primary indicators, ResMed is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Haemonetics

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Haemonetics are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of rather inconsistent basic indicators, Haemonetics exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with ResMed and Haemonetics

The main advantage of trading using opposite ResMed and Haemonetics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ResMed position performs unexpectedly, Haemonetics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Haemonetics will offset losses from the drop in Haemonetics' long position.

The idea behind ResMed Inc and Haemonetics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.